US China COVID-19 Lawsuit Judgments: The $50 Billion Deadlock

They've secured nearly US$50 billion in federal judgments, but they haven't collected a single cent. What began as a bold legal strategy by Missouri and Mississippi to hold the Chinese government accountable for pandemic-era economic damage has morphed into a high-stakes diplomatic tightrope walk that threatens to derail US-China relations.

The Legal Basis of US China COVID-19 Lawsuit Judgments

In 2025, a federal court awarded {keyword:MissouriUS$24 billion in March, followed by a {stat:US$25 billion judgment for Mississippi in November. These rulings relied on a narrow interpretation of the "commercial activity" exception to the 50-year-old Foreign Sovereign Immunities Act (FSIA). The courts argued that China's early-pandemic hoarding of personal protective equipment (PPE) like masks and gloves constituted market behavior rather than a sovereign act.

While the attorneys general of both Republican-led states have vowed to seize Chinese assets to satisfy these debts, legal experts interviewed by SCMP suggest the process is riddled with barriers. Sovereign assets are notoriously difficult to attach under international law, and Beijing remains defiant, refusing to recognize the jurisdiction of US courts in these matters.

Diplomatic Balancing Act and Retaliation

The timing couldn't be more delicate for President Donald Trump. As he seeks to stabilize trade ties, the State Department finds itself caught between state-level legal victories and federal foreign policy goals. Beijing has already filed a retaliatory lawsuit in Wuhan, escalating the legal dispute into a bilateral confrontation. With {keyword:Trump planning a high-profile visit to China in {stat:April 2026, diplomats are working behind the scenes to prevent these multi-billion dollar judgments from triggering a new round of trade tensions.